X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (171) 171
breast cancer (145) 145
female (145) 145
index medicus (140) 140
oncology (138) 138
middle aged (136) 136
aged (104) 104
adult (96) 96
breast neoplasms - drug therapy (92) 92
breast neoplasms - pathology (87) 87
cancer (62) 62
chemotherapy (62) 62
medicine & public health (62) 62
treatment outcome (57) 57
antineoplastic combined chemotherapy protocols - therapeutic use (49) 49
care and treatment (48) 48
metastasis (47) 47
prognosis (42) 42
disease-free survival (41) 41
research (39) 39
cancer research (38) 38
receptor, erbb-2 - metabolism (38) 38
surgery (37) 37
therapy (37) 37
breast neoplasms - mortality (36) 36
analysis (35) 35
clinical trials (35) 35
neoplasm staging (35) 35
survival (34) 34
breast neoplasms - surgery (33) 33
surgical oncology (32) 32
women (30) 30
breast neoplasms - metabolism (28) 28
docetaxel (28) 28
epidermal growth factor (28) 28
patients (28) 28
antineoplastic combined chemotherapy protocols - adverse effects (27) 27
male (27) 27
trial (27) 27
endocrine therapy (26) 26
cancer therapies (25) 25
japan (25) 25
oncology, experimental (25) 25
postmenopausal women (25) 25
trastuzumab (25) 25
cyclophosphamide (23) 23
chemotherapy, adjuvant (22) 22
neoplasm metastasis (22) 22
aged, 80 and over (21) 21
capecitabine (21) 21
estrogen (21) 21
multicenter (21) 21
original (21) 21
performing operations (21) 21
receptors, estrogen - metabolism (21) 21
transporting (21) 21
antimitotic agents (20) 20
antineoplastic agents (20) 20
metastatic breast cancer (20) 20
obstetrics & gynecology (20) 20
tumors (20) 20
cancer patients (19) 19
metastases (19) 19
neoadjuvant therapy (19) 19
original article (19) 19
tamoxifen (19) 19
breast neoplasms - genetics (18) 18
drug administration schedule (18) 18
hematology, oncology and palliative medicine (18) 18
kaplan-meier estimate (18) 18
taxoids - administration & dosage (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
drug therapy (17) 17
erbb-2 protein (17) 17
fluorouracil - administration & dosage (17) 17
lumpectomy (17) 17
medical colleges (17) 17
postmenopause (17) 17
retrospective studies (17) 17
anthracyclines (16) 16
chemistry (16) 16
letrozole (16) 16
paclitaxel (16) 16
toxicity (16) 16
young adult (16) 16
adjuvant treatment (15) 15
combination (15) 15
mastectomy, segmental (15) 15
paclitaxel - administration & dosage (15) 15
survival analysis (15) 15
cyclophosphamide - administration & dosage (14) 14
double-blind method (14) 14
expression (14) 14
human necessities (14) 14
medical prognosis (14) 14
medical research (14) 14
metallurgy (14) 14
pharmacology & pharmacy (14) 14
post-menopause (14) 14
product development (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (407) 407
Japanese (36) 36
French (14) 14
German (7) 7
Chinese (1) 1
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2017, Volume 28, Issue suppl_9
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 580 - 591
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 904 - 916
Summary Background Phosphatidylinositol 3-kinase (PI3K) pathway activation is a hallmark of endocrine therapy-resistant, hormone receptor-positive breast... 
Hematology, Oncology and Palliative Medicine | HETEROGENEITY | WOMEN | PALBOCICLIB | THERAPY | EXEMESTANE | ONCOLOGY | MUTATION | RESISTANCE | COMBINATION | AROMATASE INHIBITORS | PI3K INHIBITOR | Estradiol - analogs & derivatives | Humans | Middle Aged | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Alanine Transaminase - blood | Receptors, Estrogen - analysis | Fulvestrant | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Neoplasm Metastasis | Hyperglycemia - chemically induced | DNA, Neoplasm - blood | DNA Mutational Analysis | Exanthema - chemically induced | Postmenopause | Female | Morpholines - adverse effects | Aminopyridines - administration & dosage | Drug Eruptions - etiology | Double-Blind Method | Morpholines - administration & dosage | Estradiol - administration & dosage | Survival Rate | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Retreatment | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Aspartate Aminotransferases - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Medical colleges | Clinical trials | Product development | Breast cancer | Postmenopausal women | Hormones | Antineoplastic agents | Analysis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 6, pp. 523 - 533
Journal Article
Surgery Today, ISSN 0941-1291, 6/2016, Volume 46, Issue 6, pp. 668 - 685
Prior to publication of the Clavien-Dindo classification in 2004, there were no grading definitions for surgical complications in either clinical practice or... 
Clavien-Dindo classification | Medicine & Public Health | Surgical Oncology | Surgery | JCOG postoperative complications criteria (JCOG PC criteria) | Postoperative complications | COLON-CANCER | SURGERY | RANDOMIZED CONTROLLED-TRIAL | Complications and side effects | Complications | Original
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 4, pp. 345 - 352
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 8, pp. 791 - 792
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2147 - 2159
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 20, pp. 1926 - 1936
Journal Article